First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors

Clinical trial NCT06554795 · RECRUITING

Trial details

NCT number: NCT06554795
Sponsor: DualityBio Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2024-09-03
Primary completion: 2027-02-01
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.